Analyst Ratings for RxSight Inc. (RXST)
RXST Rating Summary
RXST Price Target Summary
- Highest: $11.50 (Jefferies)
- Lowest: $5.50 (UBS)
- Average: $8.83
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$8.83 (+26.4%)
* Over Last 12-Mos
Rating Score: 0.8 / 10
Percentile Rank: 6%
Avg. $ Target:
$8.83 (+26.4%)
* Over Last 12-Mos
Rating Score: 0.8 / 10
Percentile Rank: 6%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/28/2026 | UBS | Patrick Wood | New Coverage | Neutral (N/A) |
5.50 (N/A) |
5.64 (6.99) |
23.94% | Details |
| 1/30/2026 | William Blair | Steven Lichtman | New Coverage | Market Perform (N/A) |
N/A (N/A) |
8.91 (6.99) |
-21.55% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
